Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Acadia Pharmaceuticals (ACAD)

Acadia Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACAD
DateTimeSourceHeadlineSymbolCompany
17/01/202521:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
14/01/202514:05Business WireAcadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:ACADAcadia Pharmaceuticals Inc
30/12/202422:37PR Newswire (US)Acadia Pharmaceuticals Set to Join S&P SmallCap 600NASDAQ:ACADAcadia Pharmaceuticals Inc
19/12/202421:05Business WireAcadia Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 14, 2025NASDAQ:ACADAcadia Pharmaceuticals Inc
16/12/202421:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
11/12/202421:05Business WireAcadia Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 MillionNASDAQ:ACADAcadia Pharmaceuticals Inc
10/12/202423:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
10/12/202423:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
09/12/202414:00Business WireAcadia Pharmaceuticals Appoints Thomas Garner Chief Commercial OfficerNASDAQ:ACADAcadia Pharmaceuticals Inc
26/11/202421:05Business WireAcadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711NASDAQ:ACADAcadia Pharmaceuticals Inc
21/11/202421:05Business WireAcadia Pharmaceuticals to Participate at Upcoming Investor ConferencesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202401:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202401:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
20/11/202401:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
15/11/202421:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
14/11/202411:48Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACADAcadia Pharmaceuticals Inc
06/11/202421:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACADAcadia Pharmaceuticals Inc
06/11/202421:05Business WireAcadia Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operating OverviewNASDAQ:ACADAcadia Pharmaceuticals Inc
05/11/202421:05Business WireAcadia Pharmaceuticals Enters Into an Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 MillionNASDAQ:ACADAcadia Pharmaceuticals Inc
17/10/202422:41Business WireAcadia Pharmaceuticals to Announce Third Quarter Financial Results on November 6, 2024NASDAQ:ACADAcadia Pharmaceuticals Inc
16/10/202420:07Business WireAcadia Pharmaceuticals Announces Health Canada Approval of DAYBUEâ„¢ (trofinetide) for the Treatment of Rett SyndromeNASDAQ:ACADAcadia Pharmaceuticals Inc
16/10/202420:07Business WireAcadia Pharmaceuticals annonce l’approbation de DAYBUE™ (trofinétide) par Santé Canada pour le traitement du syndrome de RettNASDAQ:ACADAcadia Pharmaceuticals Inc
15/10/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
08/10/202420:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
26/09/202420:05Business WireAcadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ACADAcadia Pharmaceuticals Inc
25/09/202422:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
25/09/202422:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ACADAcadia Pharmaceuticals Inc
23/09/202421:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ACADAcadia Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACAD